---
title: "NBIO.US (NBIO.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/NBIO.US/news.md"
symbol: "NBIO.US"
name: "NBIO.US"
parent: "https://longbridge.com/en/quote/NBIO.US.md"
datetime: "2026-03-14T01:45:39.594Z"
locales:
  - [en](https://longbridge.com/en/quote/NBIO.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NBIO.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NBIO.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/NBIO.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/NBIO.US/news.md)


# NBIO.US (NBIO.US) — Related News

### [Natus introduces AVEMG innovation in launch of latest edition of Natus Elite software](https://longbridge.com/en/news/274023492.md)
*2026-01-28T17:06:00.000Z*
> Natus Medical Incorporated has launched the latest version of its Natus Elite EMG software, introducing the Augmented Vi

### [Biotalys and 21st.BIO partner to advance biocontrol production; Biotalys updates funding plans for next phase of development.](https://longbridge.com/en/news/273471372.md)
*2026-01-23T06:01:23.000Z*
> Biotalys has recently shared an update on its strategy to secure funding for the next stage of development. The company 

### [Nascent Completes Dosing Requirement in Final Cohort of Phase I Clinical Trial](https://longbridge.com/en/news/78304968.md)
*2023-01-25T00:00:00.000Z*
> NORTH PALM BEACH, FL / ACCESSWIRE / January 25, 2023 / Nascent Biotech, Inc.(OTCQB:NBIO) ("Nascent Biotech", "Nascent", 

### [Nascent Enrolls Final Patient Cohort in Phase I Brain Cancer Trial](https://longbridge.com/en/news/77296873.md)
*2023-01-10T00:00:00.000Z*
> NORTH PALM BEACH, FL / ACCESSWIRE / January 10, 2023 / Nascent Biotech, Inc.(OTCQB:NBIO) ("Nascent Biotech", "Nascent", 

### [Nascent Biotech Announces Appointment of Dr. Ivan Babic to Scientific Advisory Board](https://longbridge.com/en/news/76024009.md)
*2022-12-20T00:00:00.000Z*
> VERO BEACH, FL / ACCESSWIRE / December 20, 2022 / Nascent Biotech, Inc.(OTCQB:NBIO) ("Nascent Biotech", "Nascent", or th

### [Nascent Biotech Receives Notice of the Issuance of US Patent No.11,494,394](https://longbridge.com/en/news/72620242.md)
*2022-11-01T00:00:00.000Z*
> VERO BEACH, FL / ACCESSWIRE / November 1, 2022 / Nascent Biotech, Inc.(OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the